Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumorsMatteo Simonelli, Armando Santoro, Fabio De Vincenzo et al.|European Journal of Cancer|2012Cited by 13
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors.Matteo Simonelli, Armando Santoro, Paolo Andrea Zucali et al.|Journal of Clinical Oncology|2011Cited by 1